Nurse Practitioner, Adult Health · Rochester, NY
NPI
1366054041
Since 2020
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
4
Medicare group memberships
Hospitals
2
Hospital affiliations
160 Sawgrass Dr Ste 150
Rochester, NY, 14642
Phone (585) 273-2727
Groups this clinician bills Medicare through
Medicare paid, 2024
$12K
315 services
Medicare patients, 2024
78
Average age 74
Drug cost, 2024
$6.6M
920 prescriptions
Company payments, 2024
$225
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kasey L Weisbrod was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 120 times for 54 patients. In total Kasey L Weisbrod billed 315 services in 6 codes, and Medicare paid $12K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-02.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 120 | 54 | $10.69 | $1,283 |
| 99214 Office E&M - Established | Facility | 113 | 51 | $58.83 | $6,648 |
| 99213 Office E&M - Established | Facility | 60 | 41 | $39.00 | $2,340 |
By year: 2022 $6,075 for 110 services; 2023 $9,373 for 183 services; 2024 $12K for 315 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kasey L Weisbrod prescribed most often to Medicare patients was Calquence (Acalabrutinib Maleate), with 173 prescriptions and refills. In total Kasey L Weisbrod wrote 920 Medicare prescriptions that cost $6.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Calquence Acalabrutinib Maleate | 173 | 181 | 21 | $2.2M |
| Brukinsa Zanubrutinib | 82 | 94 | 13 | $1.2M |
| Jaypirca Pirtobrutinib | 76 | 76 | Under 11 | $1.5M |
| Imbruvica Ibrutinib | 74 | 75 | 11 | $913K |
| Venclexta Venetoclax | 52 | 52 | Under 11 | $451K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 45 | 50 | 12 | $137 |
| Prednisone Generic | 41 | 41 | 16 | $94.57 |
| Acyclovir Generic | 33 | 35 | 12 | $361 |
| Ondansetron Hcl Generic | 31 | 31 | 13 | $163 |
| Prochlorperazine Maleate Generic | 30 | 30 | 20 | $288 |
| Pantoprazole Sodium Generic | 28 | 30 | Under 11 | $106 |
| Valacyclovir Valacyclovir Hcl | 27 | 56 | Under 11 | $1,660 |
| Lenalidomide Generic | 18 | 18 | Under 11 | $248K |
| Omeprazole Generic | 18 | 18 | Under 11 | $137 |
| Eliquis Apixaban | 17 | 25 | Under 11 | $14K |
Brand drugs: 498 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Kasey L Weisbrod $225 ($225 in general payments such as food, travel and fees) from 2 companies. The largest payer was Abbvie Inc. with $166.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.